ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AZN Astrazeneca Plc

11,988.00
-38.00 (-0.32%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -38.00 -0.32% 11,988.00 12,014.00 12,018.00 12,144.00 11,882.00 12,070.00 2,340,814 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.28 186.27B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,026p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,210.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £186.27 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.28.

Astrazeneca Share Discussion Threads

Showing 3376 to 3397 of 6150 messages
Chat Pages: Latest  138  137  136  135  134  133  132  131  130  129  128  127  Older
DateSubjectAuthorDiscuss
08/12/2020
16:27
Good timing!
gateside
08/12/2020
11:38
Dipped my toe in at 7960p.

Luck to all.

philanderer
07/12/2020
17:42
Market report:

AstraZeneca was higher, boosting Pharmaceuticals, after Morgan Stanley upgraded its shares from 'equalweight' to 'overweight'.

"The rotation out of momentum, sterling strength and deterioration in vaccine sentiment has created a buying opportunity heading into a positive pipeline and earnings risk set-up in 2021," the broker said.

Alliance News

philanderer
07/12/2020
15:30
Two leading coronavirus vaccine developers -- Pfizer Inc. and AstraZeneca Plc -- have applied for emergency use authorization in India, according to the Press Trust of India, raising the likelihood that mass inoculation efforts could begin within weeks in the country of 1.3 billion people.
philanderer
07/12/2020
10:09
MORGAN STANLEY RAISES ASTRAZENECA TO 'OVERWEIGHT' ('EQUAL WEIGHT') - PRICE TARGET 9900 (9400) PENCE
philanderer
06/12/2020
17:24
"When will the Oxford vaccine be ready?
A date has not yet been set for when or if the Oxford/AstraZeneca vaccine will be approved, but there are hopes it will be confirmed before Christmas, adding a further 100 million doses of the vaccine to the UK total."

bountyhunter
04/12/2020
19:31
clickable version...
bountyhunter
04/12/2020
09:46
hxxps://www.msn.com/en-in/news/in-depth/explained-why-is-the-oxford-astrazeneca-vaccine-better-news-than-pfizer-moderna-shots/ar-BB1biIZt
turvart
04/12/2020
09:42
End sept news
ashwani01
04/12/2020
09:00
£105 target by Berenberg
demo trader
04/12/2020
08:32
Takes 2 doses. Fairly sure there are more than 20m
bogman1
04/12/2020
08:30
The UK have ordered 40M doses of the vaccine from Pfizer

Clearly it is intended to be the main thrust V Covid-19

buywell3
03/12/2020
20:53
Yes more data is needed,Astra is working on that.There's unlikely to be any approval of the Astra drug in the US until January at the earliest since Astra won't seek a submission before it has completed further trials.
steeplejack
03/12/2020
18:57
Circa £76.66 is the recent low, might be worth a look in that area.
essentialinvestor
03/12/2020
18:51
I feel that it will in UK, more vaccine doses are needed to meet Government timescales. All trial results are well above the 50% benchmark.
bountyhunter
03/12/2020
17:25
I feel in US Astra won't get the ok, more data needed.
montyhedge
03/12/2020
16:05
logistics favours an Astra style drug if it is as effective as other vaccines.Johnson & Johnson are working on a vaccine with results expected in January.

Not that i'm a great devotee of charts but just now the RSI suggests Astra is very oversold.

steeplejack
03/12/2020
16:02
My AZN are certainly not for sale.
gateside
03/12/2020
15:40
This is FX imv.
essentialinvestor
03/12/2020
15:40
The problem is if the Yank Vaccine works well

why change and

buywell3
03/12/2020
15:33
I agree Ash, the MMs are probably anticipating a rise when the vaccine is finally approved for emergency use. We can't keep paying a fortune for the US vaccines plus the huge extra costs for distribution and administering. Also there won't be enough doses of those in the time frame the Government have been promoting.
bountyhunter
03/12/2020
15:32
“The shot de­vel­oped by Ox­ford and As­tra­Zeneca works like a more tra­di-tional vac­cine, in­tro­duc­ing a weak­ened virus, in this case one found in chim-panzees, into the body to trig­ger im­mu­nity. It showed an ef­fi­cacy range of 62% to 90%, de­pend­ing on the dosage.”Wall St Journal 3 Dec

In the U.K.,the Astra drug test results have been well received but in the US it is generally regarded that results fell short of other competing vaccines.This might have impacted sentiment at the same time as sterling strength has weakened off overseas traders and sector rotation has seen switching out of Covid defensives into recovery plays.

steeplejack
Chat Pages: Latest  138  137  136  135  134  133  132  131  130  129  128  127  Older

Your Recent History

Delayed Upgrade Clock